US equities
|
NVDA
$239.24
▲+0.14%
MU
$1,045.56
▼-1.73%
SPCX
$171.92
▲+0.49%
AMD
$649.42
▲+2.80%
MRVL
$287.01
▲+5.81%
AVGO
$375.81
▲+3.67%
INTC
$112.50
▼-3.18%
MSFT
$529.30
▲+0.78%
NVDA
$239.24
▲+0.14%
MU
$1,045.56
▼-1.73%
SPCX
$171.92
▲+0.49%
AMD
$649.42
▲+2.80%
MRVL
$287.01
▲+5.81%
AVGO
$375.81
▲+3.67%
INTC
$112.50
▼-3.18%
MSFT
$529.30
▲+0.78%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Biotricity, Inc. - Common Stock
(NQ:
BTCY
)
0.4631
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biotricity, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Biotricity Launches Cardiac Application For Samsung's Watch4 Series
↗
October 07, 2021
Biotricity Inc (NASDAQ:BTCY) announced the upcom...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 07, 2021
Gainers Nanobiotix (NASDAQ:NBTX) shares rose 13.2% to $12.0 during Thursday's regular session. The market value of their outstanding shares is at $417.9 million....
Via
Benzinga
Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series
October 07, 2021
REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming release of Biocare Cardiac...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Remote Medical Diagnostic Company, Biotricity, to Ring the Nasdaq Stock Market Opening Bell on Thursday, October 7th
October 06, 2021
Founder and CEO Waqaas Al Siddiq and Members of Biotricity Management Team to Attend Opening Bell Ceremony on Thursday, October 7, 2021 at 9:30am E.T. REDWOOD CITY, CA / ACCESSWIRE / October 6, 2021 /...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Benzinga Announces The 8 'Rising Star' Companies Being Featured On Its Next 'All Access' Show
↗
October 06, 2021
Benzinga is thrilled to announce the guest lineup for our next All Access show, set to air Thursday, October 7 at 9:00 am ET. Thursday's Guest Lineup The theme...
Via
Benzinga
Biotricity to Discuss its 2022 Strategic Outlook and Product Pipeline, at Benzinga Healthcare Small Cap Conference on Sept. 30
September 28, 2021
REDWOOD CITY, CA / ACCESSWIRE / September 28, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that its Chief Executive Officer...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Biotricity to Discuss Expansion of Remote Monitoring Medical Device Products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd
September 21, 2021
Biokit is the Expansion of the Company's Bioflux Cardiac-Diagnostic Offering Kits on Track for Launch in Early 2022 REDWOOD CITY, CA / ACCESSWIRE / September 21, 2021 / Biotricity Inc. (NASDAQ:BTCY), a...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring
↗
September 15, 2021
Biotricity (NASDAQ: BTCY) is reforming the healthcare market as one of the fastest-growing companies in medtech. The company bridges the gap in remote cardiac monitoring,...
Via
Benzinga
Biotricity Unveils "Biokit" with 3 Personal Medical Devices to Expand into Cardiac Disease Management
September 14, 2021
Company Expects New Personal Medical Device Kit to be available to customer by early 2022 REDWOOD CITY, CA / ACCESSWIRE / September 14, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Biotricity Announces Closing of Exercise of Underwriter's Option to Purchase Additional Common Stock
September 13, 2021
Underwritten Public Offering of Common Stock Resulted in Total Gross Proceeds of $16 Million REDWOOD CITY, CA / ACCESSWIRE / September 13, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Biotricity to Discuss Sales Expansion, Recent Financing, and Wearable Medical Device Portfolio Expansion at H.C. Wainwright Conference
September 08, 2021
Company's Momentum Continuing with Sales Growth, Recent Nasdaq listing and Successful Equity Raise REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or...
From
Biotricity, Inc.
Via
AccessWire
Biotricity Reports Q1 Earnings at 290% for FY2022
↗
September 02, 2021
Biotricity (NASDAQ: BTCY) has been taking the world of medtech by storm, introducing primary care providers across the country to its remote heart monitoring devices. Always...
Via
Benzinga
Biotricity Uplists to Nasdaq, Poses Significant Buying Opportunity for Investors
↗
September 01, 2021
Image via Biotricity.com Thursday, August 26, 2021, Biotricity, Inc. (NASDAQ: BTCY) uplisted to Nasdaq after raising $15 million to fuel its continued growth and expansion....
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 31, 2021
Gainers Sonnet BioTherapeutics (NASDAQ:SONN
Via
Benzinga
Biotricity Completes Nasdaq Listing
↗
August 30, 2021
Closes $15 Million Underwritten Public Offering REDWOOD CITY, CA / ACCESSWIRE / August 30, 2021 / Biotricity, Inc. (NASDAQ: BTCY), a medical diagnostic and consumer...
Via
Benzinga
Biotricity Completes Nasdaq Listing
August 30, 2021
Closes $15 Million Underwritten Public Offering REDWOOD CITY, CA / ACCESSWIRE / August 30, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In A Light Week
↗
August 29, 2021
Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. and BioNTech SE. The stocks subsequently moved back and...
Via
Talk Markets
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
↗
August 29, 2021
Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. (NYSE: PFE) and BioNTech SE (...
Via
Benzinga
Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market
↗
August 27, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 26, 2021 / Biotricity, Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced...
Via
Benzinga
Who is Dr. Waqaas Al-Siddiq, and Why are His Wearables the Most Crucial Devices MedTech Has Ever Seen?
↗
August 27, 2021
Biotricity Inc. (NASDAQ: BTCY) is a medtech startup that has seen quarter-over-quarter (QoQ) growth since its inception within the cardiac arena, and just listed on the NASDAQ as...
Via
Benzinga
Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market
August 26, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 26, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the pricing of an underwritten public...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
↗
August 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...
Via
Benzinga
Biotricity Announces Proposed Underwritten Public Offering of Common Stock in Connection with Expected Nasdaq Listing
August 25, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 25, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it intends to offer shares of its...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Biotricity Reports 290% Revenue Growth Year Over Year in Record First Quarter
August 16, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 16, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to provide financial results for its fiscal...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Biotricity to Report First Quarter Fiscal 2022 Financial Results on August 16, 2021
August 12, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 12, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will release its financial...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Innovative Company Biotricity is Providing Solutions for Chronic Diseases
↗
July 15, 2021
A new study revealed that 44% of older millennials that will soon hit 40 suffer at least one chronic health condition that takes a toll, both financially and emotionally —...
Via
Benzinga
Healthy Hearts and Healthy Wallets: Why one Healthtech Startup is a Must-Invest
↗
July 14, 2021
Last month, we saw a lot of great startups at the Benzinga Global Small Cap Conference. Many of them screamed, “This is an innovation tech stock you need to buy now!...
Via
Benzinga
Biotricity's 2021 Fiscal Fourth Quarter Growth Trend Continues into Fiscal 2022
July 07, 2021
Fiscal Q1-22 to be the 9th quarter of growth and biggest quarter to date REDWOOD CITY, CA / ACCESSWIRE / July 7, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Why A Northstar Analyst Is Bullish On This Disruptive MedTech Company
↗
July 01, 2021
A strong value proposition and high retention rate have turned Northland Capital Markets bullish on Biotricity, Inc (OTC:
Via
Benzinga
Biotricity Reports Record Quarterly and Annual Revenue for Fiscal 2021
June 15, 2021
REDWOOD CITY, CA / ACCESSWIRE / June 15, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to provide unaudited, preliminary financial...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
< Previous
1
2
3
4
5
6
7
8
Next >
